rs375459945
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_016239.4(MYO15A):c.6787G>A(p.Gly2263Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 1,601,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO15A | NM_016239.4 | c.6787G>A | p.Gly2263Ser | missense_variant | Exon 33 of 66 | ENST00000647165.2 | NP_057323.3 | |
MYO15A | XM_017024715.3 | c.6790G>A | p.Gly2264Ser | missense_variant | Exon 31 of 64 | XP_016880204.1 | ||
MYO15A | XM_017024714.3 | c.6727G>A | p.Gly2243Ser | missense_variant | Exon 30 of 63 | XP_016880203.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000309 AC: 7AN: 226754Hom.: 0 AF XY: 0.0000162 AC XY: 2AN XY: 123502
GnomAD4 exome AF: 0.0000152 AC: 22AN: 1449606Hom.: 0 Cov.: 34 AF XY: 0.0000111 AC XY: 8AN XY: 720110
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74354
ClinVar
Submissions by phenotype
not provided Pathogenic:4
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36401330, 28000701, 26969326) -
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 2263 of the MYO15A protein (p.Gly2263Ser). This variant is present in population databases (rs375459945, gnomAD 0.01%). This missense change has been observed in individuals with deafness (PMID: 26969326, 28000701; internal data). ClinVar contains an entry for this variant (Variation ID: 504632). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MYO15A protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
Autosomal recessive nonsyndromic hearing loss 3 Pathogenic:1
Variant summary: MYO15A c.6787G>A (p.Gly2263Ser) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.1e-05 in 226754 control chromosomes. c.6787G>A has been reported in the literature in individuals affected with Autosomal Recessive Nonsyndromic Hearing (examples: Sloan-Heggen_2016, ZazoCelia_2016,Schobers_2025, internal data). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 39333430, 26969326, 28000701).ClinVar contains an entry for this variant (Variation ID: 504632). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Gly2263Se r variant in MYO15A has been reported in the compound heterozygous state with a pathogenic MYO15A variant in an individual with hearing loss (Sloan-Heggen 2016) . It has also been identified in 1/52508 European chromosomes by the Exome Aggre gation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs375459945); how ever, this frequency is low enough to be consistent with a recessive carrier fre quency. Computational prediction tools and conservation analyses suggest that th is variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Gly2263Ser variant is unc ertain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at